Clinical trials
Allergy clinical trials
Below are recruiting allergy clinical trials, each written for real people, not researchers. We’re tracking 323 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06069492Recruiting
Wheat oral immunotherapy for children with wheat allergy
This trial tests whether a controlled, gradual treatment called oral immunotherapy can help children with wheat allergy eat wheat safely. It involves a supervised wheat challenge first, then daily wheat doses for 12 months.
Hong KongAges 1–17 - NCT06085118Recruiting
Observatory on cow's milk protein allergy in babies
This study is watching babies with a cow's milk protein allergy who are given a special formula called Pepticate® Syneo®. It helps doctors learn how babies do on this formula over time.
NiceAges Up to 8 months - NCT06327906Recruiting
Infant allergy and brain development study in China
This study follows infants in the Jinan area of Shandong, China, who have signs of allergies, to see how allergies might relate to brain development. It aims to help understand early links between allergies and conditions like autism or ADHD.
Jinan, ShandongAges 1 minute–1 month - NCT06409884Recruiting
Amoxicillin allergy testing trial
This trial is testing a new way to diagnose allergies to amoxicillin, a common antibiotic. It may help people who think they might be allergic to amoxicillin find out for sure.
Edegem, AntwerpAges 6 years+ - NCT06467994RecruitingPhase 2
Boiled cashew nut therapy for children with cashew allergy
This trial tests whether a specially boiled cashew nut can help children with cashew allergy eat cashews without a reaction. It is for children ages 2 to 17 with a confirmed cashew allergy, and it avoids other serious health conditions.
Hong KongAges 2–17 - NCT06533462Recruiting
Slow multi-food allergy treatment in young children
This trial tests a slow, multi-food oral immunotherapy (giving small amounts of several foods) in young children with food allergies. It aims to see if this treatment can help children safely eat more foods without allergic reactions.
StockholmAges 6 months–3 years - NCT06714149Recruiting
How nitrogen pollution affects pollen allergies
This study looks at how pollution from nitrogen in the environment affects pollen allergies in Belgium. It may help explain why your allergy symptoms change depending on where you live.
Leuven, Vlaams-BrabantAges 18 years+ - NCT06732414Recruiting
Long-term study of multiple allergic diseases
This study creates a biorepository to collect and store samples (blood, nasal fluid, skin swabs) from people with allergies, asthma, sinus disorders, or immune dysregulation. It aims to better understand these conditions over time, which may help develop better treatments.
Bethesda, MarylandAges 3–100 - NCT06755281Recruiting
Testing to safely remove penicillin allergy labels
This study tests if people with a low-risk penicillin allergy can safely have the allergy label removed through a simple risk assessment and testing, without needing a full drug challenge. It aims to help more people get the right antibiotics when needed.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06923878Recruiting
Legume allergy diagnosis study with skin and blood tests
This study compares different tests to diagnose legume allergies. They look at skin prick tests, blood tests for IgE antibodies, and component-resolved diagnosis to see which works best for peas, lentils, chickpeas, and beans.
Pilsen, Czech RepublicAges 4 months–65 years - NCT06935890RecruitingPhase 4
Long-term effectiveness of jack jumper ant venom therapy
This study checks how well venom immunotherapy for jack jumper ant allergy works years after treatment ends. If you finished 3–5 years of treatment and stopped 1.5 to 5 years ago, you may be able to help.
Adelaide, South AustraliaAges 18 years+ - NCT06943534RecruitingPhase 2
Omalizumab for severe food allergies: weight-based dosing study
This trial tests if omalizumab (a drug that blocks allergy reactions) can help people with multiple food allergies. You might qualify if you have severe allergies to at least two foods like peanut, tree nuts, egg, or milk.
Boston, MassachusettsAges 1–55 - NCT07002814Recruiting
Direct oral challenge for kids with beta-lactam allergy in private practice
This trial studies a direct oral challenge (giving a small dose of the medicine by mouth) to safely confirm whether children truly have a mild, delayed allergy to certain antibiotics like amoxicillin. It aims to help remove inaccurate allergy labels so kids can use these common antibiotics if needed.
ParisAges Up to 17 years - NCT07015996RecruitingPhase 2
Tezepelumab for peanut allergy oral immunotherapy
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
Little Rock, ArkansasAges 12–55 - NCT07133074RecruitingPhase 4
Testing penicillin allergy labels in blood cancer patients
This trial checks whether people with blood cancers who think they are allergic to penicillin or related antibiotics can safely take these medicines again. It aims to remove incorrect allergy labels to improve treatment options.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07197814Recruiting
Tolerance of a rice protein formula in children with cow's milk allergy
This study tests a new formula made from rice protein in children who have a cow's milk allergy. It checks if the rice formula is well-tolerated without causing allergic reactions.
NaplesAges 1 month–3 years - NCT07309432RecruitingPhase 3
Birch allergy shot study for eye symptoms
This trial tests a new antibody treatment for eye allergy symptoms caused by birch pollen. It may help if you have severe eye allergies during birch season.
Andover, MassachusettsAges 12 years+ - NCT07309822Recruiting
Beltaven® venom allergy immunotherapy study
This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.
Barcelona, BarcelonaAges 14 years+ - NCT07341776RecruitingPhase 4
Testing steroids for food allergy reactions
This trial tests whether using a steroid drug can help treat allergic reactions to food. If you have a food allergy that causes immediate symptoms (like hives or trouble breathing), this study may help find better ways to manage those reactions.
Basel, BaselAges 6 months–18 years - NCT07342621Recruiting
Testing a special formula for babies with cow's milk allergy
This study tests whether a special formula with added prebiotics, probiotics, and a human milk nutrient helps manage symptoms in infants with cow's milk protein allergy. If your baby is starting a hypoallergenic formula for the first time, this trial may be an option.
Valencia, ValenciaAges Up to 10 months - NCT07349212RecruitingPhase 1/Phase 2
Study of UKK-0018 for peanut allergy treatment
This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.
Camperdown, New South WalesAges 18–55 - NCT03352193Recruiting
Oral wheat tolerance treatment for children with wheat allergy
This trial tests a supervised “oral tolerance induction” approach, which means giving carefully controlled wheat exposure to try to train the immune system to tolerate wheat. It’s designed for children who have confirmed IgE-mediated wheat allergy, aiming to reduce allergic reactions over time.
AthensAges 2–16 - NCT02497261Enrolling by invitation
Study factors that predict peanut allergy at age five
This study looks at which early test results and symptoms help predict whether a child will still have a peanut allergy by age 5. It may help families and doctors better understand who is at higher risk and plan next steps.
Ages 4–10 - NCT01832324Enrolling by invitation
Study the causes of food allergy using blood samples
This study looks for the biological reasons behind food allergies by collecting a small amount of blood. It may help scientists better understand different types of food allergy and eventually improve diagnosis or treatments.
Philadelphia, PennsylvaniaAges 1 month–65 years
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for allergy?
- Yes. Clin2 currently lists 323 recruiting allergy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a allergy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a allergy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.